Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 9, 2004

View Archived Issues

New modulators of farnesoid X receptors covered by X-Ceptor patent

Novel FAP-activated prodrugs with utility in cancer therapy

Kowa describes new PPARalpha agonists, their preparation and use

Yamanouchi patents novel ApoB-related lipoprotein secretion inhibitors

Bayer scientists claim new pyrimidine-based antiproliferative agents

Update on Generex technologies

Enrollment stopped in phase II of Velcade for metastatic colorectal cancer

FDA approval for Invirase boosted with ritonavir for HIV

Restructuring at D-Pharm completed

GT-1061 advances into phase I safety study for Alzheimer's

U.S. enrollment commences for phase II SDX-105 study

BCY Lifesciences seeking partner or licensee for DCF-987

Zavesca launched in U.S.

Dosing commences in pivotal PRECIS-1 study of CDP-870 for Crohn's disease

Chemokine Therapeutics files for U.S. orphan drug designation for CTCE-9908

Andrx and Takeda to develop Actos/Fortamet combination product

Organon pays Cortex milestone to retain AMPAKINE technology rights

Long-term effectiveness of olanzapine and haloperidol in schizophrenia

ISV-205 limits IOP increase induced by corticosteroids

Long-term use of lipid-lowering drugs reported to improve when started in an inpatient setting

A new phase II clinical trial to evaluate two furosemide formulations in CHF patients

Oxycyte(TM) to enter phase II testing during 2004

Tularik's T-131 is being assessed in patients with type 2 diabetes

Dynogen Pharmaceuticals announces collaboration with Johnson & Johnson

Corixa Corporation announces NIH biodefense partnership

Aventis Pharma and Avalon Pharmaceuticals form collaboration

XenoPort announces collaboration with Pfizer

PCALC-36, a new Na+/K+-ATPase inhibitor with a unique mechanism of action

Primaquine derivative shows good antimalarial activity and less toxicity

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 10, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026